Benefit of Using Renal Sodium-Glucose Cotransporter Inhibitors 2 (iSGLT-2) in Patients With Type 2 Diabetes Mellitus and Heart Failure. Acervo Saúde 2020, 12 (9), e4349. https://doi.org/10.25248/reas.e4349.2020.